Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-813
Closed -$44K 7428
2020
Q3
$44K Sell
813
-59
-7% -$3.24K ﹤0.01% 5681
2020
Q2
$42K Buy
872
+465
+114% +$20.5K ﹤0.01% 6127
2020
Q1
$14K Sell
407
-3,311
-89% -$182K ﹤0.01% 6886
2019
Q4
$233K Buy
3,718
+3,602
+3,105% +$204K ﹤0.01% 5060
2019
Q3
$6K Sell
116
-58
-33% -$2.74K ﹤0.01% 7267
2019
Q2
$8K Buy
+174
New +$8.38K ﹤0.01% 7361

Other funds holding ENOV

Citigroup's ENOV Position: Q1 2026 in Review

Citigroup reduced its Enovis (ENOV) stake by 96% in Q1 2026, selling an estimated $5.76M and leaving 9,715 shares worth $221K. The position accounts for ﹤0.01% of the portfolio, ranked #3965.

Citigroup first reported a position in ENOV in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.5M in Q1 2025. 254 funds tracked by Wall St. Rank hold ENOV as of Q1 2026.

  • Citigroup held 9,715 shares of Enovis worth $221K as of Q1 2026.
  • Citigroup sold 243,580 Enovis shares in Q1 2026, an estimated $5.76M.
  • Enovis made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3965 holding.
  • Citigroup first reported a position in Enovis in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Enovis position peaked at $12.5M in Q1 2025.
  • 254 funds tracked by Wall St. Rank held Enovis as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.